Allergy Drug Development Report
Download the Beacon Allergies Report to stay updated on the latest developments in the field. Interest in allergies has grown exponentially and the report covers the latest findings.
Don’t miss out on valuable insights for your drug development strategies.
The report includes:
- An in-depth analysis of the current allergy trial landscape showcasing the shifts in focus and development phases.
- Beacon Immune Tolerance is currently keeping a record of 226 drugs that are being studied for allergies. The report provides detailed information on the drugs being investigated for each specific type of allergy.
- The report explores the formulation of allergy drugs. Injection is the preferred formulation, but oral formulations are gaining traction due to high compliance and cost-effectiveness.
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
